MRM Wins Novartis Aclasta European CRM Business

Share this content:
Novartis tapped MRM Worldwide, an interactive and relationship marketing company, to undertake European patient communications for its Aclasta CRM program, it was announced yesterday.


Aclasta is an annual infusion for the treatment of Paget's disease and is in the third phase of clinical trials for other metabolic bone disorders such as osteoporosis.


Novartis said it also is considering letting MRM Worldwide pitch for all of its global CRM opportunities.


MRM Partners, a unit of McCann Worldgroup, which is owned by Interpublic Group of Companies, has 62 offices in 37 countries, more than 1,700 employees and clients such as Coca-Cola, Dell, General Motors, Intel, Royal Bank of Scotland Group, Tesco, UPS, Unilever and Vodafone.


Sign up to our newsletters

Company of the Week

Since 1985, Melissa has helped thousands of companies clean, correct and complete contact data to better target and communicate with their customers. We offer a full spectrum of data quality solutions, including global address, phone, email, and name validation, identify verification - available for batch or real-time processes, in the Cloud or on-premise. Our service bureau provides dedupe, email/phone append and geographic/demographic append services for better targeting and insight. For direct mailers, Melissa offers easy-to-use address management/postal software, list hygiene services and 100s of specialty mailing lists - all with competitive pricing and excellent customer service.

Find out more here »

Career Center

Check out hundreds of exciting professional opportunities available on DMN's Career Center.  
Explore careers in digital marketing, sales, eCommerce, marketing communications, IT, data strategies, and much more. And don't forget to update your resume so employers can contact you privately about job opportunities.

>>Click Here